Your session is about to expire
← Back to Search
CorCap CSD + Mitral Valve Repair for Heart Failure (MVR + CorCap Trial)
MVR + CorCap Trial Summary
This trial is to see if the addition of the CorCapTM CSD to mitral valve surgery can help improve heart function in patients with heart failure.
MVR + CorCap Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMVR + CorCap Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- I am scheduled for a heart surgery that is not mitral valve replacement.I have heart rhythm problems that affect my blood flow.I have a heart condition where my heart's main pumping chamber is enlarged.I am on a stable heart failure treatment as per US guidelines.You have a medical condition that makes it unsafe for you to use a machine to circulate your blood outside of your body.I haven't used any heart support devices or specific heart medications in the last 30 days.You are expected to need a heart transplant within the next two years.I had a heart procedure within the last 3 months.I have a thickened heart muscle that obstructs blood flow.My heart is too large for the CorCap CSD device.I have heart adhesions that may prevent complete access to my heart.You currently need or will need a special device to help your heart pump blood.Your heart's left ventricle is a certain size, as measured by a specific heart test.I currently have an infection.I am between 18 and 80 years old.I have late-stage heart failure and am considered high-risk for surgery.I have moderate to severe mitral regurgitation and am scheduled for valve repair or replacement.My heart's pumping ability is reduced (LVEF ≤ 45%).My heart condition limits my physical activity.I have a functioning coronary artery bypass graft.I have a health condition that may shorten my life to under a year.I have not had a heart attack, unstable angina, stroke, or mini-stroke in the last 3 months.Unable to complete a maximum effort exercise test as determined by the CPX Core Lab.I am a candidate for surgery to improve blood flow, as confirmed by an angiogram.You were a control patient in a previous CorCap PMA randomized trial.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has this treatment been granted approval by the Federal Drug Administration?
"Our team at Power gave this treatment a safety rating of 2, since the Phase 2 trial only provides evidence for its security and not efficacy."
Who has the opportunity to sign up for this investigation?
"This clinical trial seeks 50 individuals aged 18 to 80 with heart failure. To be eligible for participation, applicants must meet the following criteria: Angiotensin-converting enzyme inhibitors (ACE) or alternate if ACE not tolerated for a period of no less than 1 month prior to enrollment; Treatment with beta-blockers unless deemed intolerant by medical professionals and taken consistently over 3 months before enrolment time; Dilated cardiomyopathy originating from ischemic or non-ischemic sources; Cardiac medications remaining unchanged during the span of one complete month except diuretic adjustments when necessary; Mitral regurgitation greater than"
Are there opportunities for participation in this trial presently available?
"This medical trial, which first appeared on the clinicaltrials.gov database in 2008 and was last edited in 2009, is not currently seeking participants. Nonetheless, there are 700 other studies that remain actively recruiting patients today."
Is this research endeavor open to participants who are octogenarians?
"To be eligible for this scientific research, participants must meet the age requirements of 18-80. For individuals younger than 18 and adults over 65, there are 22 studies and 690 studies respectively conducted to address their needs."
Are there a variety of sites in the US currently executing this clinical study?
"This clinical trial has 12 participating health centres, such as Newark Beth Israel in Newark, Advocate Christ Medical Center in Oak Lawn, and Royal Victoria Hospital - McGill University in Montreal. Additionally, there are an additional 9 medical sites that are part of the study."
Share this study with friends
Copy Link
Messenger